Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 34
Filtrer
1.
Arq Gastroenterol ; 61: e23195, 2024.
Article de Anglais | MEDLINE | ID: mdl-38896575

RÉSUMÉ

BACKGROUNDS: Fortunately, much has been studied about COVID-19 in patients with inflammatory bowel diseases (IBD). Evidence suggests that these patients do not appear to be at increased risk of severe COVID-19. However, there are still some uncertainties regarding the clinical manifestations of COVID-19 in patients with immune-mediated diseases. OBJECTIVE: This study aimed to describe the main symptoms of COVID-19 and their frequency in IBD patients and evaluate the impact of the IBD therapeutic drugs on clinical presentation of COVID-19 and to determine factors associated with COVID-19 in this population. METHODS: Adult patients with IBD from three tertiary-care public, teaching hospitals in Ceará, Northeastern Brazil, were evaluated during one scheduled appointment from March to December 2020. Patients with possible or confirmed COVID-19 were compared with patients without COVID-19. Furthermore, incidences of each symptom were evaluated based on the use of IBD therapeutic drugs. RESULTS: A total of 515 patients with IBD were included in the study: 234 with CD, and 281 with UC. Of these, 174 patients (34%) had possible/confirmed COVID-19 of whom 156 (90%) were symptomatic. Main symptoms were fever (65%) and headache (65%); gastrointestinal symptoms occurred in one third of patients and were higher than COVID-19 in general population. The factors associated with having COVID-19 were female gender (OR 1.71, 95%CI: 1.17-2.50); contact at home (OR 5.07, 95%CI: 3.31-7.78) and outside the home (OR 3.14, 95%CI: 2.10-4.71) with a case of COVID-19; work outside of the home (OR 1.87, 95%CI: 1.26-2.78); family history of COVID-19 (OR 2.29, 95%CI 1.58-3.33) use of salicylate (OR 1.71, 95%CI: 1.17-4.28); and asthma (OR 7.10, 95%CI: 1.46-34.57). CONCLUSION: IBD patients at high risk of COVID-19 infection may need to avoid salicylate therapy but further studies are necessary to confirm this association.


Sujet(s)
COVID-19 , Maladies inflammatoires intestinales , Salicylates , Humains , COVID-19/complications , Femelle , Mâle , Adulte , Maladies inflammatoires intestinales/traitement médicamenteux , Maladies inflammatoires intestinales/complications , Adulte d'âge moyen , Salicylates/effets indésirables , Salicylates/usage thérapeutique , Brésil/épidémiologie , SARS-CoV-2 , Facteurs de risque , Sujet âgé
2.
Rev. Ciênc. Agrovet. (Online) ; 22(2): 234-241, mai. 2023. graf, tab
Article de Portugais | VETINDEX | ID: biblio-1445004

RÉSUMÉ

A aplicação dereguladores de crescimento vegetal representa uma alternativa para atenuar a ocorrência de estresse nos cultivos, tais como períodos de escassez hídrica na canola (Brassica napusL.) Diante disso, objetivou-se avaliar a aplicação de ácido salicílico no desenvolvimento inicial da cultura da canola submetida a déficit hídrico. O experimento foi conduzido em casa de vegetação, no delineamento experimental de blocos casualizados em esquema fatorial 5 x 2, composto por cinco doses de ácido salicílico (0; 0,5; 1,0; 1,5 e 2,0 mM L-1) e dois regimes hídricos, com e sem déficit hídrico (25% e 80% da capacidade de vaso), com quatro repetições. As variáveis analisadas foram injúrias visuais, altura de plantas, teor de clorofila e massaseca da parte aérea. A aplicaçãode diferentes doses de ácido salicílico não apresentou diferenças significativas em relação a não aplicação. O déficit hídrico resultou em maior porcentagem de injúrias, menor altura e massa seca de plantas, indicando a ocorrência de estresse à cultura. Aaplicação de ácido salicílico não atenuou os efeitos do déficit hídrico, assim como não demonstrou efeitos benéficos no desenvolvimento das plantas de canola.(AU)


The application of plant growth regulators represents an alternative to attenuate the occurrence of stress in crops, such as periods of water scarcity in canola (Brassica napus L.). Therefore, the objective was to evaluate the application of salicylic acid in the initial development of the crop. of canola subjected to water deficit. The experiment was carried out in a greenhouse, in a randomized block design in a 5 x 2 factorial scheme, consisting of five doses of salicylic acid (0; 0.5; 1.0; 1.5 and 2.0 mM L-1) and two water regimes, with and without water deficit (25% and 80% of vessel capacity), with four replications. The variables analyzed were visual injuries, plant height, chlorophyll content and shoot dry mass. The application of different doses of salicylic acid did not present significant differences in relation to non-application. The water deficit resulted in a higher percentage of injuries, lower height and dry mass of plants, indicating the occurrence of stress to the crop. The application of salicylic acid did not attenuate the effects of water deficit, as well as it did not demonstrate beneficial effects on the development of canola plants.(AU)


Sujet(s)
Salicylates/effets indésirables , Brassica napus/physiologie , Déshydratation/diagnostic , Facteur de croissance végétal/physiologie
3.
Rev. Ciênc. Agrovet. (Online) ; 22(2): 274-284, mai. 2023. ilus, tab, graf
Article de Portugais | VETINDEX | ID: biblio-1451284

RÉSUMÉ

As características pós-colheita dos produtos agrícolas são influenciadas por diversos fatores como a cultivar, as condições ambientais, as práticas culturais e sistemas de produção. A conservação pós-colheita é um dos desafios da cadeia produtiva de flores de corte. Com isso, objetiva-se avaliar concentrações de ácido salicílico, temperatura e períodos dearmazenamento na conservação de hastes florais de gladíolo provenientes do sistema de plantio direto orgânico. O trabalho foi realizado na Universidade Federal da Fronteira Sul -Campus Laranjeiras do Sul-PR. A realização do experimento ocorreu no períodode 31 de dezembro de 2020 até 18 de janeiro de 2021. Foram utilizadas hastes de gladíolo cultivar Yester, advindas do cultivo com e sem cobertura de solo. Para essa pesquisa foram realizados dois experimentos. O primeiro consiste em um delineamento experimental inteiramente casualizado, em esquema trifatorial (cobertura de solo (2) x temperatura de armazenamento (2) x período de armazenamento (9)). Sendo com e sem cobertura, em duas temperaturas de armazenamento (5 °C) ± 2 °C) e (20 ± 2 °C), nos períodos de armazenamento 0 a 16 dias. O segundo experimento, possui delineamento experimental inteiramente casualizado, em esquema trifatorial (concentrações de ácido salicílico (5) x (temperaturas de armazenamento (2) x período de armazenamento (10)). Nas concentrações de 0,0; 0,5; 1,0; 1,5 e 2,0 mM de ácido salicílico em duas temperaturas de armazenamento (5 °C) ± 2 °C) e (20 ± 2 °C), nos períodos de armazenamento 0 a 18 dias. As avaliações realizadas foram: ataque de lagartas, diâmetro da haste, tortuosidade da haste, comprimento de botão basal-apical, números de floretes abertos e números de floretes senescentes. Para ambos os experimentos, os tratamentos influenciaram nas respostas de número de floretes abertos e número de floretes senescentes. O uso de ácido salicílico na concentração de 0,5 Mm associado a temperatura refrigerada e hastes florais oriundas do sistema de cultivo com cobertura proporcionam prolongamento da conservação de hastes florais de gladíolo.(AU)


The post-harvest characteristics of agricultural products are influenced by several factors such as the cultivar, environmental conditions, cultural practices, and production systems. Post-harvest conservation is one of the challenges of the cut flower production chain. With this, the objective is to evaluate salicylic acid concentrations, temperature and storage periods in the conservation of gladiolus floral stems from the organic no-tillage system.The work was carried out at the Federal University of Fronteira Sul -Campus Laranjeiras do Sul-PR. The experiment took place from December 31, 2020 to January 18, 2021. Stems of gladiolus cultivar Yester, from cultivation with and without ground cover. For this research, two experiments were carried out. The first consists of a completely randomized experimental design, in a three-factor scheme (soil cover (2) x storage temperature (2) x storage period (9)). With and without cover, at two storage temperatures (5 °C) ± 2 °C) and (20 ± 2 °C), in storage periods from 0 to 16 days. The second experiment has a completely randomized design, in a three-factor scheme (salicylic acid concentrations (5) x (storage temperatures (2) x storage period (10)). 0, 1.5, and2.0 mM salicylic acid at two storage temperatures (5 °C) ± 2 °C) and (20 ± 2 °C), in storage periods from 0 to 18 days. The evaluations carried out were: caterpillar attack, stem diameter, stem tortuosity, basal-apical bud length, number of open florets rand number of senescent florets. For both experiments, the treatments influenced the responses of a number of open florets and number of senescent florets. The use of salicylic acid at a concentration of 0.5 Mm associated with refrigerated temperature and floral stems from the cover crop system provide an extension of the conservation of gladiolus floral stems.(AU)


Sujet(s)
Température , Salicylates/effets indésirables , Agriculture biologique/méthodes , Asparagales/physiologie , Entreposage de données/méthodes
4.
Rev. Ciênc. Agrovet. (Online) ; 22(3): 429-438, ago. 2023. graf, tab
Article de Portugais | VETINDEX | ID: biblio-1451515

RÉSUMÉ

O objetivo neste trabalho foi verificar a influência da aplicação de diferentes concentrações de ácido salicílico e distintas coberturas de solo no cultivo de physalis (Physalis peruviana L). O trabalho foi desenvolvido na área experimental da Universidade Federal da Fronteira Sul, Laranjeiras do Sul-PR. Foram utilizadas mudas de physalis produzidas em casa de vegetação. A campo foram submetidas a cinco concentrações de ácido salicílico (0, 0,001, 0,002, 0,003, 0,004 Mol L-¹), e três coberturas de solo (palhada de gramínea, eucalipto e testemunha sem palhada). Nas avaliações de pré-colheita, o delineamento experimental foi de blocos ao acaso, em esquema fatorial 3x5. Para as avaliações pós-colheita o delineamento experimental foi 3x5x2, sendo considerado também o mês de colheita. Não houve interação entre os fatores para as variáveis analisadas. Para altura e diâmetro, presença de insetos, incidência e severidade de doenças foliares, somente o fator concentrações de ácido salicílico influenciou. Na pós-colheita somente o mês de colheita interferiu nos fatores, sendo a colheita de setembro com maior número e massa dos frutos, mas também o maior ataque de insetos e doenças. Concluiu-se com este trabalho que a aplicação de ácido salicílico influenciou no desenvolvimento de plantas de physalis.(AU)


The objective of this work was to verify the influence of the application of different concentrations of salicylic acid and different soil coverings in the cultivation of physalis (Physalis peruvianaL). The work was developed in the experimentalarea of the Federal University of Fronteira Sul, Laranjeiras do Sul-PR. Physalis seedlings produced in a greenhouse were used. The field was subjected to five concentrations of salicylic acid (0, 0,001, 0,002, 0,003, 0,004 Mol L-¹), and three soil coverings (grass straw, eucalyptus and control without straw). In the pre-harvest evaluations, the experimental design was randomized blocks, in a 3x5 factorial scheme. For post-harvest evaluations, the experimental design was 3x5x2, and the month of harvest was also considered. There was no interaction between the factors for the analyzed variables. For height and diameter increase and presence of insects, incidence and severity of leaf diseases, only the factor of salicylic acid influences. In the post-harvestperiod, only the month of harvest interfered in the factors, with the September harvest having the largest number and mass of fruits, but also the greatest attack by insects and diseases. It was concluded with this work that the application of salicylic acid influenced the development of physalis plants.(AU)


Sujet(s)
24444 , Analyse du Sol , Salicylates/effets indésirables , Physalis/croissance et développement
5.
Immunopharmacol Immunotoxicol ; 34(6): 1028-38, 2012 Dec.
Article de Anglais | MEDLINE | ID: mdl-22712758

RÉSUMÉ

Bornyl salicylate (BS) is a salicylic derivative, obtained by sterification of salicylic acid and monoterpene (-)-borneol, and its topical use in inflammatory diseases was described in the early 20th century. It is also known that borneol presents neuroprotective, genoprotective and analgesic properties. The purpose of this study was to evaluate BS in experimental models of acute inflammation. The toxicity of BS was analyzed by measuring water and food intake, weight, mortality and weight of main organs. To assess its anti-inflammatory effect, BS-treated mice were challenged with carrageenan, prostaglandin E2 (PGE2), bradikynin (BK) or histamine (HIS)-induced paw edema, zymosan-induced peritonitis and vascular permeability induced by acetic acid. Nitric oxide (NO) production was analyzed in peritoneal macrophage cultures. There was no sign of acute toxicity of BS in male and female mice. Furthermore, treatment with BS was significantly (p < 0.05) effective in reducing paw edema induced by carrageenan in early and late phases; this effect was related to PGE2 and BK, but HIS independent. Neutrophil migration and cytokine release (TNF-α, IL-1ß and IL-6) induced by zymosan and fluid leakage induced by acetic acid were also reduced in BS-treated animals. In vitro, BS (10 µg/mL) reduced NO production in LPS-stimulated macrophages. These data suggest that BS has an anti-inflammatory effect, which is related, at least in part, with decrease of mediators as PGE2, NO and pro-inflammatory cytokines. However, further studies should be done to explore its potential as an anti-inflammatory drug.


Sujet(s)
Anti-inflammatoires non stéroïdiens , Salicylates , Animaux , Anti-inflammatoires non stéroïdiens/effets indésirables , Anti-inflammatoires non stéroïdiens/synthèse chimique , Anti-inflammatoires non stéroïdiens/composition chimique , Anti-inflammatoires non stéroïdiens/pharmacologie , Bradykinine/pharmacologie , Carragénane/pharmacologie , Mouvement cellulaire/effets des médicaments et des substances chimiques , Cytokines/métabolisme , Dinoprostone/pharmacologie , Évaluation préclinique de médicament , Consommation alimentaire/effets des médicaments et des substances chimiques , Femelle , Lipopolysaccharides/toxicité , Macrophages péritonéaux/métabolisme , Macrophages péritonéaux/anatomopathologie , Mâle , Souris , Granulocytes neutrophiles/métabolisme , Granulocytes neutrophiles/anatomopathologie , Monoxyde d'azote/biosynthèse , Ocytociques/pharmacologie , Péritonite/induit chimiquement , Péritonite/traitement médicamenteux , Péritonite/métabolisme , Péritonite/anatomopathologie , Salicylates/effets indésirables , Salicylates/synthèse chimique , Salicylates/composition chimique , Salicylates/pharmacologie , Vasodilatateurs/pharmacologie , Zymosan/toxicité
6.
Rev Inst Med Trop Sao Paulo ; 52(3): 163-7, 2010.
Article de Anglais | MEDLINE | ID: mdl-20602028

RÉSUMÉ

Although elderly populations are more exposed to the risk of getting dengue, the clinical peculiarities of this disease in this age range are not well known. This report is about an 80-year-old woman with dengue complications, self-medicated with salicylate. Literature indicates a more severe clinical condition, high hospitalization rate and significant mortality. This is caused by previous infections by other serotypes of this arbovirus, presence of chronic diseases, immunosenescence and high drug consumption, especially salicylates and the like. Analyses are required in a public health perspective in order to help health professionals that care for patients with dengue in this age range.


Sujet(s)
Dengue/diagnostic , Automédication/effets indésirables , Sujet âgé de 80 ans ou plus , Anti-inflammatoires non stéroïdiens/effets indésirables , Dengue/thérapie , Femelle , Hospitalisation , Humains , Salicylates/effets indésirables , Indice de gravité de la maladie
7.
Rev. Inst. Med. Trop. Säo Paulo ; Rev. Inst. Med. Trop. Säo Paulo;52(3): 163-167, May-June 2010. tab
Article de Anglais | LILACS | ID: lil-550352

RÉSUMÉ

Although elderly populations are more exposed to the risk of getting dengue, the clinical peculiarities of this disease in this age range are not well known. This report is about an 80-year-old woman with dengue complications, self-medicated with salicylate. Literature indicates a more severe clinical condition, high hospitalization rate and significant mortality. This is caused by previous infections by other serotypes of this arbovirus, presence of chronic diseases, immunosenescence and high drug consumption, especially salicylates and the like. Analyses are required in a public health perspective in order to help health professionals that care for patients with dengue in this age range.


Embora cada vez mais populações idosas estejam expostas ao risco de contrair dengue, pouco se sabe sobre peculiaridades clínicas desta doença nesta faixa etária, fato este que motivou este relato sobre octogenária com dengue agravada por automedicação de salicilato. A literatura consultada aponta para quadro clínico mais grave, elevado índice de hospitalizações e mortalidade significativa. Deve-se isto a infecções prévias com outros sorotipos desta arbovirose, presença de doenças crônico degenerativas, imunosenescência e alto consumo de medicamentos, particularmente salicilatos e similares. Análises, sob a ótica da saúde pública, são necessárias para auxiliar aos profissionais de saúde que assistem pacientes com dengue nesta faixa etária


Sujet(s)
Sujet âgé de 80 ans ou plus , Femelle , Humains , Dengue/diagnostic , Automédication/effets indésirables , Anti-inflammatoires non stéroïdiens/effets indésirables , Dengue/thérapie , Hospitalisation , Indice de gravité de la maladie , Salicylates/effets indésirables
9.
Rev Assoc Med Bras (1992) ; 48(4): 312-6, 2002.
Article de Portugais | MEDLINE | ID: mdl-12563458

RÉSUMÉ

UNLABELLED: The aim of this paper was to perform a randomized, controlled and blinded study to investigate if a therapeutic dose of acetylsalicylic acid (ASA), taken by pregnant women, may also cause embryotoxic or congenital abnormalities on experimental animal. METHODS: Females were confirmed to have mated by observations of sperm in a vaginal smear. The day on which spermatozoa were found in the vaginal smear was considered as day 1 of gestation (GD1). After randomization, mated females were assigned to experimental groups and individually caged, were given 50 mg/kg/day of acetylsalicylic acid, by needle gavage once daily, during two different periods of pregnancy. One group of dams (n=11) received aspirin from day 1 to 4 of pregnancy (before embryonic implantation) for evaluation of the blastocysts, and another group received aspirin from day 6 to 15 of pregnancy (organogenic period) for fetal evaluation. Control groups (n=12) received distilled water in same volume and during same periods as their respective experimental groups. RESULTS AND CONCLUSION: The treatment of the dams with ASA, according to minimal therapeutic dose used for humans, did not cause embryotoxic or major malformations on experimental animal but was responsible for rate increased of fetuses presenting ureteric dilatation. After analysis of the data, it appears that, although direct conclusive evidence of adverse effects in humans is lacking, a potential hazard dose exists and thus the indiscriminate use of acetylsalicylic acid (aspirin) is contraindicated.


Sujet(s)
Gestation animale/effets des médicaments et des substances chimiques , Salicylates/effets indésirables , Animaux , Acide acétylsalicylique/administration et posologie , Acide acétylsalicylique/effets indésirables , Blastomères/effets des médicaments et des substances chimiques , Relation dose-effet des médicaments , Évaluation préclinique de médicament , Femelle , Foetus/effets des médicaments et des substances chimiques , Grossesse , Répartition aléatoire , Rats , Rat Wistar , Salicylates/administration et posologie , Méthode en simple aveugle
11.
Pediatria (Säo Paulo) ; 20(2): 126-36, abr.-jun. 1998.
Article de Portugais | LILACS | ID: lil-224977

RÉSUMÉ

Os medicamentos com acao analgesica, antitermica e antiinflamatoria(11) sao muito utilizados em adultos e criancas. Apesar de serem considerados medicamentos seguros, e de muitos analgesicos serem comercializados sem necessidade de prescricao medica, esses farmacos podem causar significantes eventos adversos, especialmente em criancas. Neste artigo, a autora apresenta uma revisao sobre a toxicidade desses medicamentos sobre diversos orgaos e enfatiza que muitos AA comercializados no Brasil ainda nao foram aprovados para uso infantil em outros paises, pois se desconhece a incidencia de seus efeitos adversos


Sujet(s)
Humains , Analgésiques/toxicité , Anti-inflammatoires/toxicité , Analgésiques/classification , Analgésiques/effets indésirables , Anti-inflammatoires/effets indésirables , Anti-inflammatoires/classification , Système nerveux central/effets des médicaments et des substances chimiques , Système digestif/effets des médicaments et des substances chimiques , Métamizole sodique/effets indésirables , Rein/effets des médicaments et des substances chimiques , Salicylates/effets indésirables
13.
Homeopatía (B. Aires) ; 60(3): 213-4, 1995.
Article de Espagnol | LILACS | ID: lil-207821

RÉSUMÉ

Comunicación de un caso de Natrum Silicylicum producido por sensibilidad ante la aplicación de un complejo inyectable que provocara sordera y ruido en oído derecho, claramente curado por el medicamento simillimum al caso


Sujet(s)
Humains , Femelle , Adulte , Natrum Salicylum/usage thérapeutique , Surdité/thérapie , Salicylates/effets indésirables , Composés de l'iode/effets indésirables , Perte d'audition/étiologie , Perte d'audition/thérapie
14.
Homeopatía [Argent.] ; 60(3): 213-4, 1995.
Article de Espagnol | BINACIS | ID: bin-19431

RÉSUMÉ

Comunicación de un caso de Natrum Silicylicum producido por sensibilidad ante la aplicación de un complejo inyectable que provocara sordera y ruido en oído derecho, claramente curado por el medicamento simillimum al caso (AU)


Sujet(s)
Humains , Femelle , Adulte , Natrum Salicylum/usage thérapeutique , Surdité/thérapie , Perte d'audition/étiologie , Perte d'audition/thérapie , Salicylates/effets indésirables , Composés de l'iode/effets indésirables
15.
Cuad. Hosp. Clín ; 39(1): 24-7, 1993. tab
Article de Espagnol | LILACS | ID: lil-157890

RÉSUMÉ

Se presentan 77 niños intoxicados que ingresaron a la Unidad de Cuidados intensivos del Hospital del niño de la ciudad de La Paz, en el periodo comprendido entre julio de 1985 a septiembre de 1988.Se analizo edad, sexo, agente toxico, causa de intxicacion, fuente de origen, gravedad, estancia, en el servicio de estdo de alta. Los medicamentos constituyeron el 53.2 por ciento , destacando en primer lugar los salicilatos. Los agentes no medicamentososrepresentaron el 46.7 por ciento producidos fundamentalmente por insecticidas organofosforados. La edad mas frecuente contemplo a menores de 4 años. No se encontro diferencias entre ambos sexos. La ingestion accidental fue la principal causa de intoxicacion y ocurrio principalmente en el hogar. La gravedad fue moderada en 53 por ciento y severa en el 47 por ciento . Fallecieron 10 pacientes (13 por ciento ). El tiempo promedio de estancia en el servicio fue de dos dias y medio. Se insiste en medidas de prevencion, educacion, utilidad del jarabe de Ipeca y, fundamentalemente en nuestro medio, la necesidad de implementar el Centro de Intoxicados.


Sujet(s)
Humains , Mâle , Femelle , Intoxication/complications , Salicylates/effets indésirables , Insecticides Organophosphorés/effets indésirables , Insecticides Organophosphorés/intoxication
18.
Rev Infect Dis ; 12 Suppl 1: S64-7, 1990.
Article de Anglais | MEDLINE | ID: mdl-2406858

RÉSUMÉ

During the months of July 1977 and July 1985, students from the United States participated in a double-blind, placebo-controlled trial examining the effectiveness of liquid bismuth subsalicylate (BSS) (1977) and two dosages of the tablet formulation of BSS (1985) in preventing diarrhea while in Guadalajara, Mexico. In the first study, 62 subjects received BSS for 3 weeks at a dosage of 60 mL four times daily (4.2 g of BSS/d) compared with 66 students receiving an oral placebo at a similar dosage schedule. In the second study, 51 students took two tablets four times daily (2.1 g of BSS/d), 63 took one tablet four times daily (1.05 g of BSS/d), and 58 took a placebo (two tablets taken four times daily), each for 3 weeks. In the initial study, 14 (23%) BSS-treated subjects developed diarrhea compared with 40 (61%) placebo-tested persons (P less than .0001). In the second trial, seven (14%) subjects taking two tablets of BSS four times daily, 15 (24%) taking one tablet of BSS four times daily, and 23 (40%) receiving placebo tablets experienced diarrhea (P less than .001 for the higher dose). The percent protection provided by BSS was 62% for the group that received 4.2 g/d, 65% for 2.1 g/d, and 40% for 1.05 g/d, when compared with the corresponding placebo group. In cases in which stools were analyzed, seven (24%) of 29 BSS-treated subjects who had diarrhea had a detectable enteric pathogen, compared with 35 (59%) of 59 of those randomized to receive a placebo. BSS was well tolerated.(ABSTRACT TRUNCATED AT 250 WORDS)


Sujet(s)
Bismuth/usage thérapeutique , Diarrhée/prévention et contrôle , Composés organométalliques/usage thérapeutique , Salicylates/usage thérapeutique , Adulte , Bismuth/effets indésirables , Méthode en double aveugle , Femelle , Humains , Mâle , Mexique , Composés organométalliques/effets indésirables , Essais contrôlés randomisés comme sujet , Salicylates/effets indésirables , Voyage , États-Unis
19.
Bol. Hosp. Univ. Caracas ; 19(27): 43-8, dic. 1989.
Article de Espagnol | LILACS | ID: lil-89836

RÉSUMÉ

La intoxicación por salicilados es poco común en nuestra unidad de cuidados intensivos de adultos. Se produce como consecuencia de un bloqueo en la generación de adenosin trisfosfato y produce una alcalosis respiratoria primaria con una elevación del anión gap. El intensivista debe estar enterado de esta intoxicación por cuanto ella puede simular una cetoacidosis diabética o alcohólica, un evento cerebrovascular, sépsis y un síndrome de dificultas respiratoria del adulto de diferente etiología. El tratamiento incluye el lavado gástrico preccóz, diuresis forzada, alcalinización, hemoperfusión y en los casos más severos la hemodiálisis


Sujet(s)
Adulte , Mâle , Femelle , Hémoperfusion , Intoxication/thérapie , Salicylates/effets indésirables , Salicylates/métabolisme
20.
JAMA ; 257(10): 1347-50, 1987 Mar 13.
Article de Anglais | MEDLINE | ID: mdl-3820443

RÉSUMÉ

Within 48 hours of arrival in Mexico, 182 US students participated in a study to compare the efficacy of two dosages of bismuth subsalicylate (262 mg per tablet) as a prophylactic agent against diarrhea. The students were randomly assigned to receive two tablets (high dose) or one tablet (low dose) of bismuth subsalicylate four times daily or a placebo four times daily during a three-week period. Among these completing the trial, diarrhea (four or more unformed stools in 24 hours or three in eight hours, plus one other symptom) occurred in seven (14%) of 51 receiving the high-dose regimen compared with 15 (24%) of 63 receiving the low-dose regimen and 23 (40%) of 58 in the placebo group. Protection rates were 65% for high-dose and 40% for low-dose bismuth subsalicylate. Diarrhea caused by enterotoxigenic Escherichia coli was found in one student receiving the high-dose regimen, in no students receiving the low-dose regimen, and in seven placebo-treated subjects. Bismuth subsalicylate was well tolerated; the most common side effects were blackening of tongues and stools. Bismuth subsalicylate use in both dosages was associated with tinnitus at a low, clinically insignificant frequency of 1.2 days per 100 days of treatment. The dosage of two tablets of bismuth subsalicylate four times daily (2.1 g/d) appears to be a safe and effective means of reducing the occurrence of travelers' diarrhea among persons at risk for periods up to three weeks.


Sujet(s)
Bismuth , Diarrhée/prévention et contrôle , Composés organométalliques/usage thérapeutique , Salicylates/usage thérapeutique , Voyage , Adulte , Diarrhée/microbiologie , Humains , Mexique , Composés organométalliques/administration et posologie , Composés organométalliques/effets indésirables , Probabilité , Répartition aléatoire , Salicylates/administration et posologie , Salicylates/effets indésirables , Comprimés
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE